Article Versions Notes

Grützmeier SE, Kovacevic B, Vilmann P, Rift CV, Melchior LC, Holmström MO, Brink L, Hassan H, Karstensen JG, Grossjohann H, et al. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. Cancers. 2023; 15(14):3677. https://doi.org/10.3390/cancers15143677

Grützmeier, Simon Ezban, Bojan Kovacevic, Peter Vilmann, Charlotte Vestrup Rift, Linea Cecilie Melchior, Morten Orebo Holmström, Lene Brink, Hazem Hassan, John Gásdal Karstensen, Hanne Grossjohann, and et al. 2023. "Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer" Cancers 15, no. 14: 3677. https://doi.org/10.3390/cancers15143677

Grützmeier, S. E., Kovacevic, B., Vilmann, P., Rift, C. V., Melchior, L. C., Holmström, M. O., Brink, L., Hassan, H., Karstensen, J. G., Grossjohann, H., Chiranth, D., Toxværd, A., Hansen, C. P., Høgdall, E., Hasselby, J. P., & Klausen, P. (2023). Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. Cancers, 15(14), 3677. https://doi.org/10.3390/cancers15143677